RenovoRx RNXT
NASDAQ RNXT
$1.22 +0.04 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST

RenovoRx (RNXT) Non Operating Interest Expenses (2020 - 2021)

Updated

RenovoRx's Non Operating Interest Expenses was $208,000 in Q3 2021, up 11.8% from $186,000 a year earlier.

Analysis

RenovoRx (RNXT) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 417.00 Mn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 350.00 Mn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 135.00 Mn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 186.00 Mn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 143.00 Mn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 100.00 Mn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn -
10 RenovoRx 56.86 Mn 17.54 Mn 878,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 208,000.00
Sep 30, 2020 186,000.00
API Access

RenovoRx Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RNXT&period=max&api_key=YOUR_API_KEY